N
TIL icon

Nuveen’s Instil Bio TIL Stock Holding History

Nuveen’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-941
Closed -$12K – 3138
2022
Q4 		$12K Sell
941
-10,658
-92% -$527K ﹤0.01% 3161
2022
Q3 		$1.12M Sell
11,599
-134
-1% -$15.3K ﹤0.01% 2695
2022
Q2 		$1.08M Buy
11,733
+2,283
+24% +$323K ﹤0.01% 2746
2022
Q1 		$2M Sell
9,450
-1,476
-14% -$345K ﹤0.01% 2506
2021
Q4 		$3.65M Buy
10,926
+8,065
+282% +$3.11M ﹤0.01% 2278
2021
Q3 		$1.13M Sell
2,861
-61
-2% -$22.8K ﹤0.01% 2949
2021
Q2 		$1.13M Buy
+2,922
New +$1.08M ﹤0.01% 2964

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Nuveen's TIL Position: Q1 2023 in Review

Nuveen sold out of Instil Bio (TIL) in Q1 2023, closing a stake of 941 shares — an estimated $12K sold.

Nuveen first reported a position in TIL in Q2 2021 and held it in 7 quarters. The position peaked at $3.65M in Q4 2021. 73 funds tracked by Wall St. Rank hold TIL as of Q1 2023.

  • Nuveen reported no remaining Instil Bio position as of Q1 2023 after selling out during the quarter.
  • Nuveen sold 941 Instil Bio shares in Q1 2023, an estimated $12K.
  • Nuveen first reported a position in Instil Bio in Q2 2021 and held it in 7 quarters.
  • Nuveen's Instil Bio position peaked at $3.65M in Q4 2021.
  • 73 funds tracked by Wall St. Rank held Instil Bio as of Q1 2023.

Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.